Feasibility and safety of platinum-doublet therapy in patients with small-cell lung cancer in the third-line setting: A multi-institutional retrospective study

Small-cell lung cancer (SCLC) is a highly malignant tumor, and no standard third-line therapy has been established. The present study retrospectively analyzed the efficacy and safety of platinum-based regimens in patients with third-line SCLC who received third-line chemotherapy. The association of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Takashi, Makiguchi, Tomonori, Tanaka, Yusuke, Chubachi, Kei, Ishidoya, Mina, Suzuki, Sachio, Tanaka, Hisashi, Taima, Kageaki, Hasegawa, Yukihiro, Okudera, Koichi, Tasaka, Sadatomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494349/
https://www.ncbi.nlm.nih.gov/pubmed/36238842
http://dx.doi.org/10.3892/ol.2022.13488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494349/
https://www.ncbi.nlm.nih.gov/pubmed/36238842
http://dx.doi.org/10.3892/ol.2022.13488

Ejemplares similares